medigraphic.com
ISSN 0016-3813 (Print)

2017, Number 3

<< Back Next >>

Gac Med Mex 2017; 153 (3)

Conferencia Dr. Ignacio Chávez: Caminando hacia una medicina molecular

García-Sáinz JA

Language: Spanish
References: 48
Page: 379-382
PDF size: 71.86 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Langley JN. On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. J Physiol. 1905;33:374-413.

  2. Robert L, Labat-Robert J, Robert AM. Receptors and aging: dedicated to the memory of Paul Ehrlich for the 100th anniversary of his Nobel Prize. Arch Gerontol Geriatr. 2010;51:260-3.

  3. Butcher RW, Robison GA. An appreciation of Earl Sutherland. Metabolism. 1975;24:237-40.

  4. Raju TN. The Nobel chronicles. 1971: Earl Wilbur Sutherland, Jr. (1915- 74). Lancet. 1999;354:961.

  5. Ahlquist RP. Historical perspective. Classification of adrenoreceptors. J Auton Pharmacol. 1980;1:101-6.

  6. Oliver G, Schafer EA. The physiological effects of extracts of the suprarenal capsules. J Physiol. 1895;18:230-76.

  7. Abel JJ, Crawford AC. On the blood-pressure raising constituent of the suprarenal capsule. Bull Johns Hopkins Hosp. 1897;7:151.

  8. Takamine J. The isolation of the active principle of the suprarenal gland. J Physiol. 1901;27:30p-1p.

  9. García-Sainz JA. Adrenaline and its receptors: one hundred years of research. Arch Med Res. 1995;26:205-12.

  10. Insel PA. Seminars in medicine of the Beth Israel Hospital, Boston. Adrenergic receptors − evolving concepts and clinical implications. N Engl J Med. 1996;334:580-5.

  11. Frishman WH. Fifty years of beta-adrenergic blockade: a golden era in clinical medicine and molecular pharmacology. Am J Med. 2008;121:933-4.

  12. Hoffman BB. Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists. En: Hardman JGL, Gilman AG, editores. Goodman and Gilman’s. The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 215-68.

  13. Berthelsen S, Pettinger WA. A functional basis for classification of alpha- adrenergic receptors. Life Sci. 1977;21:595-606.

  14. Fain JN, García-Sáinz JA. Role of phosphatidylinositol turnover in alpha 1 and of adenylate cyclase inhibition in alpha 2 effects of catecholamines. Life Sci. 1980;26:1183-94.

  15. Burns TW, Langley PE, Terry BE, et al. Pharmacological characterizations of adrenergic receptors in human adipocytes. J Clin Invest. 1981;67:467-75.

  16. Garcia-Sainz JA, Boyer JL, Michel T, et al. Effect of pertussis toxin on alpha 2-adrenoceptors: decreased formation of the high-affinity state for agonists. FEBS Lett. 1984;172:95-8.

  17. García-Sáinz JA, Hoffman BB, Li SY, et al. Role of alpha 1 adrenoceptors in the turnover of phosphatidylinositol and of alpha 2 adrenoceptors in the regulation of cyclic AMP accumulation in hamster adipocytes. Life Sci. 1980;27:953-61.

  18. Boyer JL, Garcia A, Posadas C, et al. Differential effect of pertussis toxin on the affinity state for agonists of renal alpha 1- and alpha 2-adrenoceptors. J Biol Chem. 1984;259:8076-9.

  19. García-Sáinz JA. Decreased sensitivity to alpha 2 adrenergic amines, adenosine and prostaglandins in white fat cells from hamsters treated with pertussis vaccine. FEBS Lett. 1981;126:306-8.

  20. Hazeki O, Ui M. Modification by islet-activating protein of receptor-mediated regulation of cyclic AMP accumulation in isolated rat heart cells. J Biol Chem. 1981;256:2856-62.

  21. Sekura RD. Pertussis toxin: a tool for studying the regulation of adenylate cyclase. Methods Enzymol. 1985;109:558-66.

  22. García-Sáinz JA, Ruiz-Puente J, Jiménez-Paredes J, et al. Comparative biological activities of whole cell pertussis vaccine and a new acellular preparation. Vaccine. 1985;3:23-6.

  23. García-Sáinz JA, Romero-Ávila MT, Ruiz-Arriaga A, et al. Characterization and detoxification of an easily prepared acellular pertussis vaccine. Antigenic role of the A protomer of pertussis toxin. Vaccine. 1992;10:341-4.

  24. García-Sáinz JA. Mecanismo celular de acción de la toxina pertussis. En: Paredes O, Estrada S, editores. Descubrimientos y aportaciones científicas y humanísticas mexicanas en el siglo XX. Ciudad de México: Fondo de Cultura Económica; 2008. p. 291-300.

  25. Escotto-Velázquez J. Semblanza del Dr. Eduardo Liciaga. Revista Médica del Hospital General de México. 1999;62:237-9.

  26. Lefkowitz RJ. A brief history of G-protein coupled receptors (Nobel Lecture). Angew Chem Int Ed Engl. 2013;52;6366-78.

  27. García-Sáinz JA. Robert Lefkowitz y Brian Kobilka: premios Nobel 2012. Revista de la Facultad de Medicina. 2013;56:59-63.

  28. García-Sáinz JA. El Premio Nobel de Química 2012: Lefkowtiz y Kobilka. Educación Química. 2013;24:79-81.

  29. Fredriksson R, Schioth HB. The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol. 2005;67:1414-25.

  30. Fredriksson R, Lagerstrom MC, Lundin LG, et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 2003;63:1256-72.

  31. Kobilka B. The structural basis of G-protein-coupled receptor signaling (Nobel Lecture). Angew Chem Int Ed Engl. 2013;52:6380-8.

  32. García-Sáinz JA, Torres-Padilla ME. Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat-1 fibroblasts stably expressing alpha1d-adrenoceptors. FEBS Lett. 1999;443:277-81.

  33. Ziani K, Gisbert R, Noguera MA, et al. Modulatory role of a constitutively active population of alpha(1D)-adrenoceptors in conductance arteries. Am J Physiol Heart Circ Physiol. 2002;282:H475-81.

  34. Gisbert R, Ziani K, Miquel R, et al. Pathological role of a constitutively active population of alpha(1D)-adrenoceptors in arteries of spontaneously hypertensive rats. Br J Pharmacol. 2002;135:206-16.

  35. Villalobos-Molina R, Ibarra M. Vascular alpha 1D-adrenoceptors: are they related to hypertension? Arch Med Res. 1999;30:347-52.

  36. Villalobos-Molina R, López-Guerrero JJ, Ibarra M. Functional evidence of alpha1D-adrenoceptors in the vasculature of young and adult spontaneously hypertensive rats. Br J Pharmacol. 1999;126:1534-6.

  37. Kenakin T. New bull’s-eyes for drugs. Sci Am. 2005;293:50-7.

  38. Kenakin T. Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci. 2007;28:407-15.

  39. Kenakin TP. A pharmacology primer: theory, applications, and methods. Amsterdam: Elsevier Academic Press; 2009.

  40. Brinkmann V, Billich A, Baumruker T, et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov. 2010;9:883-97.

  41. Choi JW, Gardell SE, Herr DR, et al. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc Natl Acad Sci U S A. 2011;108:751-6.

  42. Tsien RY. The green fluorescent protein. Annu Rev Biochem. 1998;67:509-44.

  43. Castillo-Badillo JA, Cabrera-Wrooman A, García-Sáinz JA. Visualizing G protein-coupled receptors in action through confocal microscopy techniques. Arch Med Res. 2014;45:283-93.

  44. Castillo-Badillo JA, Sánchez-Reyes OB, Alfonzo-Méndez MA, et al. Alpha1B- adrenergic receptors differentially associate with Rab proteins during homologous and heterologous desensitization. PLoS One. 2015;10:e0121165.

  45. Alfonzo-Méndez MA, Hernández-Espinosa DA, Carmona-Rosas G, et al. Protein kinase C activation promotes alpha1B-adrenoceptor internalization and late endosome trafficking through Rab9 interaction. Role in heterologous desensitization. Mol Pharmacol. 2017;91:296-306.

  46. Salahpour A, Espinoza S, Masri B, et al. BRET biosensors to study GPCR biology, pharmacology, and signal transduction. Front Endocrinol (Lausanne). 2012;3:105.

  47. Salahpour A, Masri B. Experimental challenge to a ‘rigorous’ BRET analysis of GPCR oligomerization. Nat Methods. 2007;4:599-600; author reply 1.

  48. Shrestha D, Jenei A, Nagy P, et al. Understanding FRET as a research tool for cellular studies. Int J Mol Sci. 2015;16:6718-56.




2020     |     www.medigraphic.com